SL, W., DL, P., FE, M., R, L., DS, C., GE, B., . . . JN, R. (2001). NASPE policy statement. Consensus statement on indications, guidelines for use, and recommendations for follow-up of implantable cardioverter defibrillators. Pacing & Clinical Electrophysiology, 24(2), 262. https://doi.org/10.1046/j.1460-9592.2001.00262.x
Chicago Style (17th ed.) CitationSL, Winters, Packer DL, Marchlinski FE, Lazzara R, Cannom DS, Breithardt GE, Wilber DA, Camm AJ, and Ruskin JN. "NASPE Policy Statement. Consensus Statement on Indications, Guidelines for Use, and Recommendations for Follow-up of Implantable Cardioverter Defibrillators." Pacing & Clinical Electrophysiology 24, no. 2 (2001): 262. https://doi.org/10.1046/j.1460-9592.2001.00262.x.
MLA (9th ed.) CitationSL, Winters, et al. "NASPE Policy Statement. Consensus Statement on Indications, Guidelines for Use, and Recommendations for Follow-up of Implantable Cardioverter Defibrillators." Pacing & Clinical Electrophysiology, vol. 24, no. 2, 2001, p. 262, https://doi.org/10.1046/j.1460-9592.2001.00262.x.